I am sure Dr Poon would have enough clout. He very well regarded. It’s just not our main focus at present. US and Europe is where it is at. Once we get CE mark, TGA should be relatively easy.
There are some processes we have to repeat for the FDA in order to start the Pivitol trial and so things just take time.
Ann: Data Update on First-in-Human Study of DurAVR at NY Valves, page-18
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.80 |
Change
0.020(0.20%) |
Mkt cap ! $207.1M | |||
| Open | High | Low | Value | Volume |
| $9.85 | $10.78 | $9.60 | $572.9K | 57.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5627 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.00 | 931 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |